gefitinib has been researched along with technetium in 2 studies
Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (technetium) | Trials (technetium) | Recent Studies (post-2010) (technetium) |
---|---|---|---|---|---|
5,231 | 566 | 2,919 | 20,202 | 443 | 1,434 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angelo, LS; Gong, J; Kohanim, S; Kurzrock, R; Yang, DJ | 1 |
Chuttani, K; Dhawan, D; Ghai, A; Kumar, P; Mishra, AK; Mittal, BR; Singh, B | 1 |
2 other study(ies) available for gefitinib and technetium
Article | Year |
---|---|
Molecular imaging of gefitinib activity in an epidermal growth factor receptor (EGFR)-bearing xenograft model.
Topics: Animals; Apoptosis; Blotting, Western; Cell Line, Tumor; Cysteine; ErbB Receptors; Female; Flow Cytometry; Gefitinib; Humans; Immunoprecipitation; Indium Radioisotopes; Mice; Mice, Nude; Molecular Imaging; Neoplasms, Glandular and Epithelial; Phosphorylation; Protein Kinase Inhibitors; Quinazolines; Radionuclide Imaging; Technetium; Tissue Distribution; Xenograft Model Antitumor Assays | 2009 |
Preclinical evaluation of (99m)Tc labeled gefitinib as a potential scintigraphic probe for the detection of tumors expressing epidermal growth factor receptors.
Topics: Animals; Carcinoma, Ehrlich Tumor; Cell Line, Tumor; Contrast Media; ErbB Receptors; Gefitinib; Humans; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Inbred BALB C; Molecular Probe Techniques; Molecular Probes; Quinazolines; Rabbits; Radionuclide Imaging; Reproducibility of Results; Sensitivity and Specificity; Technetium; Tissue Distribution | 2015 |